CONSUN PHARMA (01681) spent 2.6422 million Hong Kong dollars on repurchasing 178,000 shares on December 17th.
Kangmin Pharmaceutical (01681) announced that on December 17, 2025, the company repurchased 178,000 shares at a cost of HKD 2.6422 million, with a repurchase price of HKD 14.78-14.96 per share.
CONSUN PHARMA (01681) announced that on December 17, 2025, the company spent 2.6422 million Hong Kong dollars to repurchase 178,000 shares at a repurchase price of 14.78-14.96 Hong Kong dollars per share.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
